Extendicare Inc.
EXE.TOTSXHealthcare● Active
$32.99
$-0.15(-0.45%)
Market Cap$3.1B
P/E Ratio—
52W High$35.62
52W Low$12.12
Extendicare Inc. (EXE.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EXE.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.66B | $1.47B | $1.30B | $1.22B | $1.17B |
| Cost of Revenue | $1.46B | $1.30B | $1.14B | $1.14B | $1.05B |
| Gross Profit | $0.20B | $0.17B | $0.17B | $0.08B | $0.12B |
| Gross Margin %(computed) | 12.02% | 11.46% | 12.85% | 6.29% | 9.91% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $1.20B | $0.06B | $1.04B | $0.96B |
| Total Operating Expenses | $0.06B | $0.06B | $0.06B | $0.05B | $0.05B |
| Operating Income | $0.14B | $0.11B | $0.06B | $0.02B | $0.05B |
| Operating Margin %(computed) | 8.33% | 7.59% | 4.82% | 1.72% | 4.26% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| Income Before Tax | $0.13B | $0.10B | $0.04B | ($0.00B) | $0.01B |
| Income Tax Expense | $0.03B | $0.02B | $0.01B | $0.00B | $0.01B |
| Net Income | $0.10B | $0.08B | $0.03B | $0.07B | $0.01B |
| Net Margin %(computed) | 5.82% | 5.13% | 2.60% | 5.69% | 0.99% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.13 | $0.97 | $0.40 | $-0.05 | $0.13 |
| Wtd Avg Shares | 0.09B | 0.08B | 0.08B | 0.09B | 0.09B |
| EBITDA | $0.18B | $0.16B | $0.10B | $0.05B | $0.07B |
| EBITDA Margin %(computed) | 10.58% | 10.59% | 7.56% | 4.00% | 5.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · B
Explore more Extendicare Inc. data
About Extendicare Inc. (EXE.TO) Income Statement
Extendicare Inc. (EXE.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EXE.TO reported revenue of $1.66B, gross profit of $0.20B (gross margin 12.02%), and net income of $0.10B — a net profit margin of 5.82%.
Frequently asked questions
EXE.TO · 4 questionsExtendicare Inc. (EXE.TO) reported revenue of $1.66B for 2025, up 13.2% year-over-year.
EXE.TO revenueEXE.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08